Article
Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients.
Pharmacogenetics and genomics - 1 Mar 2009
Huang Sheng-Wen, Chen Hai-Sheng, Wang Xian-Qun, Huang Ling, Xu Ding-Li, Hu Xiao-Jia, Huang Zhi-Hui, He Yong, Chen Kai-Ming, Xiang Dao-Kang, Zou Xiao-Ming, Li Qiang, Ma Li-Qin, Wang Hao-Fei, Chen Bao-Lin, Li Liang, Jia Yan-Kai, Xu Xiang-Min
Abstract excerpt
OBJECTIVES: To develop a warfarin-dosing algorithm that could be combined with pharmacogenomic and demographic factors, and to evaluate its effectiveness in a randomized prospective controlled clinical trial. METHODS: A pharmacogenetics-based dosing model was derived using retrospective data from 266 Chinese patients and multiple linear regression analysis. To prospectively validate this model, 156 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
